Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Jul 13;8(3):8.

Hypocitraturia despite potassium citrate tablet supplementation

Affiliations
Case Reports

Hypocitraturia despite potassium citrate tablet supplementation

Chetan Shenoy. MedGenMed. .

Abstract

Citrate supplementation is widely used in the prevention of recurrent nephrolithiasis with hypocitraturia. Potassium citrate is the most commonly used citrate agent for this indication. In patients with chronic diarrheal syndromes, the absorption of potassium citrate can be affected. We describe a patient who presented with recurrent nephrolithiasis and chronic diarrhea and was found to have severe hypocitraturia despite citrate supplementation with potassium citrate tablets, likely due to inadequate gastrointestinal absorption of citrate from the slow-release wax-matrix tablets.

PubMed Disclaimer

References

    1. Simpson DP. Citrate excretion: a window on renal metabolism. Am J Physiol. 1983;244:F223–F234. - PubMed
    1. Nicar MJ, Skurla C, Sakhaee K, Pak CY. Low urinary citrate excretion in nephrolithiasis. Urology. 1983;21:8–14. - PubMed
    1. Pattaras JG, Moore RG. Citrate in the management of urolithiasis. J Endourol. 1999;13:687–692. - PubMed
    1. Menon M, Mahle CJ. Urinary citrate excretion in patients with renal calculi. J Urol. 1983;129:1158–1160. - PubMed
    1. Leumann E, Hoppe B, Neuhaus T. Management of primary hyperoxaluria: efficacy of oral citrate administration. Pediatr Nephrol. 1993;7:207–211. - PubMed

Publication types

LinkOut - more resources